- Supported exchanges /
- F /
- 8WK.F
ABERA BIOSCIENCE AB (8WK F) stock market data APIs
Abera Bioscience AB, a platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally. The company's development platform named BERA, uses for the display of antigens at the surface of outer membrane vesicles derived from genetically optimized gram-negative bacteria. Its lead vaccine candidate is a universal pneumococcal vaccine based on the platform BERA. The company also develops projects in immuno-oncology, Chlamydia, ETEC, Covid-19, and Tuberculosis. Abera Bioscience AB was incorporated in 2012 and is based in Uppsala, Sweden.
ABERA BIOSCIENCE AB Financial Data Overview
| 0.323 | |
| 0.318 | |
| - | |
| 0.323 | |
| 0.312 | |
| 0.291-0.514 | |
| 5 201 K | |
| 15 352 K | |
| 9 256 K | |
| 1.052 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
ABERA BIOSCIENCE AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 9 256 K
- EBITDA 0
- Earnings Per Share -0.05
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get ABERA BIOSCIENCE AB Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get ABERA BIOSCIENCE AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
